Journal of Comprehensive Pediatrics

Published by: Kowsar

Shwachman Score in Clinical Evaluation of Cystic Fibrosis

Soheila Khalilzadeh 1 , Maryam Hassanzad 1 , Nooshin Baghaie 1 , Nazanin Parsanejad 1 , Mohammad Reza Boloursaz 1 and Fanak Fahimi 2 , *
Authors Information
1 Pediatric Respiratory Disease Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University, Tehran, IR Iran
2 Chronic Respiratory Disease Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University, Tehran, IR Iran
Article information
  • Journal of Comprehensive Pediatrics: February 25, 2013, 4 (1); 82-5
  • Published Online: October 20, 2012
  • Article Type: Research Article
  • Received: July 1, 2012
  • Revised: August 28, 2012
  • Accepted: September 11, 2012
  • DOI: 10.17795/compreped-4558

To Cite: Khalilzadeh S, Hassanzad M, Baghaie N, Parsanejad N, Boloursaz M R, et al. Shwachman Score in Clinical Evaluation of Cystic Fibrosis, J Compr Ped. 2013 ; 4(1):82-5. doi: 10.17795/compreped-4558.

Copyright © 2012, Iranian Society of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Davis PB. Cystic fibrosis since 1938. Am J Respir Crit Care Med. 2006; 173(5): 475-82[DOI][PubMed]
  • 2. Moss RB. Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis. Chest. 2002; 121(1): 55-63[DOI][PubMed]
  • 3. Jaffe A, Bush A. Cystic fibrosis: review of the decade. Monaldi Arch Chest Dis. 2001; 56(3): 240-7[PubMed]
  • 4. Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med. 1996; 335(3): 179-88[DOI][PubMed]
  • 5. Goss CH, Mayer-Hamblett N, Kronmal RA, Ramsey BW. The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases. Ad Drug Deli Rev. 2002; 54(11): 1505-28[DOI]
  • 6. Cystic fibrosis in the 20th century : people, events, and progress. 2001;
  • 7. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med. 1996; 154(5): 1229-56[PubMed]
  • 8. Katz JN, Horwitz RI, Dolan TF, Shapiro ED. Clinical features as predictors of functional status in children with cystic fibrosis. J Ped. 1986; 108(3): 352-8[DOI]
  • 9. Shwachman H, Kulczycki LL. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child. 1958; 96(1): 6-15[PubMed]
  • 10. Dankert-Roelse JE, te Meerman GJ. Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre. Thorax. 1995; 50(7): 712-8[DOI][PubMed]
  • 11. Taussig LM, Kattwinkel J, Friedewald WT, di Sant'Agnese PA. A new prognostic score and clinical evaluation system for cystic fibrosis. J Ped. 1973; 82(3): 380-90[DOI]
  • 12. Helbich TH, Heinz-Peer G, Eichler I, Wunderbaldinger P, Gotz M, Wojnarowski C, et al. Cystic fibrosis: CT assessment of lung involvement in children and adults. Radiology. 1999; 213(2): 537-44
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments